PRZOOM - /newswire/ - Amherst, NH, United States, 2010/01/11 - As the pharmaceutical industry attempts to improve productivity and lower the business risks associated with new drug candidates, drug developers are increasingly turning to a generation of new, often proprietary, formulation and delivery technologies.

These technologies can modulate release profiles to achieve dosage forms that enhance patient outcomes, compliance and safety. Controlled-release oral dosage forms can often yield a decrease in the dosing frequency and a reduction in peak plasma concentrations.

Drug formulation technology companies are working with drug developers to help define the prescription formulations that will enter preclinical development and the clinical trial pipeline in the coming months and years. The formulation capabilities will expand the number of new NCEs that can be formulated to meet pharmacochemical thresholds.

Growth in controlled release formulations is driven in part by the dramatic increase in generic drugs and generic drug companies. These off-patent APIs often suffer from sub-optimal pharmacokinetics and unpleasant side effects, issues which can often be addressed by proprietary formulation platforms. As generic drug suppliers search for ways to increase the marketability and positioning of their products, the number of controlled release technology formulations entering the marketplace will accelerate.

A new report examines the implications of these trends on pharmaceutical drug discovery and development. Controlled Release Drug Delivery Systems: Technology, Therapeutics Demand Factors and Prospects contains analysis of commercial modified release drug technologies, assessments of market, technology and demand factors, and profiles of drug formulation technology companies.

More information is available at Greystone Associates on the web.

About Greystone

Greystone Associates (greystoneassociates.org) is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Agency / Source: Greystone Associates

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

Distribution / Indexing: [+]